Fresh analysis indicates that individuals who discontinue new GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds far faster than those who stop conventional diet and exercise regimens.
Published data in a prominent medical journal shows that while obese individuals can lose a large proportion of their total mass while undergoing treatment, the weight comes back at an average rate of nearly a kilo each month after stopping.
"Individuals purchasing these medications need to be cognizant of the potential of rapid weight regain when the treatment concludes," warns lead investigator Dr. Susan Jebb.
This pace of regain suggests a reversion to starting weight in about a year and a half.
Analyzing Approaches
The analysis, which looked at 37 of trials involving over 9,000 of patients, compared the effects of the injectable medications with conventional dieting.
The team note that people who shed pounds through diet and exercise usually experience a more gradual creep back—perhaps 100 grams monthly—post-intervention.
Understanding the Fast Regain
Nutrition scientists believe the mode of action of the drugs accounts for the accelerated regain.
GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production might result in the system to produce less of its endogenous GLP-1, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this hormone supplement leads to hunger is uncontrolled, making overeating much more probable."
A Chronic Issue?
The NHS advise the injections for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians say that, due to the likelihood of weight regain, the therapy should be considered long-term.
This opinion is reinforced by drug manufacturers, who state that the findings "highlight the chronic character of excess weight," similar to managing diseases like hypertension.
User Experiences
People who have stopped the jabs report a sudden resurgence of appetite.
"I experienced something that goes on and you're instantly extremely hungry," described one woman.
This challenge is exacerbated if users have not developed lasting lifestyle or habit modifications during treatment.
Growing Adoption
Figures show that a significant number of adults in the UK have tried these injections in the past year, with demand remaining high.
- Use is greater among females compared to males.
- The middle-aged demographic shows the highest level of interest.
- Many access the drugs through private healthcare rather than the NHS.
In conclusion, clinicians emphasize that while the jabs are powerful agents for weight loss, they are not a magic cure and maintained weight loss likely depends on ongoing lifestyle support.
